Literature DB >> 8653221

Nasal mucociliary clearance in perennial rhinitis.

J F Schuhl1.   

Abstract

Mucociliary clearance is one of the homeostatic systems of the respiratory mucosa. Alterations in mucociliary clearance have been extensively studied in asthma, but less frequently in allergic rhinitis. In rhinitis, conflicting results have arisen: while some authors reported no change, others noticed a reduction in nasal mucociliary clearance. The aim of this study was to compare the nasal mucociliary clearance in allergic and non-allergic patients with perennial rhinitis and a healthy control group. One hundred and three patients and 14 healthy control subjects were studied. Nasal mucociliary clearance was assayed with the saccharin test modified with a food dye to add a visual parameter. Patients were divided into allergic and non-allergic rhinitis according to the presence of three of the following factors: total serum IgE above 180 KIU/L, positive skin prick tests to a battery of standardized allergens relevant to Uruguay, family and personal history of atopic diseases, and blood eosinophilia above 450 cells/mm3. The aspect of the nasal mucosa was not considered for categorizing the patients. Fifty-seven patients (29 males, mean age: 22.2 years) with allergic perennial rhinitis and 46 patients (15 males, mean age: 24.8 years) with non-allergic perennial rhinitis were compared with 14 controls (6 males, mean age: 35 years). A significant difference in nasal mucociliary clearance was observed between the three groups, with a mean of 8.8 minutes for the controls, 10.27 minutes for allergic rhinitis and 11.73 minutes for non-allergic patients. We suggest that the differences we observed were due to changes in the rheology of nasal mucus as a consequence of the underlying inflammatory process in rhinitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8653221

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  7 in total

1.  Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder.

Authors:  L Thorsson; O Borgâ; S Edsbäcker
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 2.  Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.

Authors:  Samuel K Lai; Ying-Ying Wang; Justin Hanes
Journal:  Adv Drug Deliv Rev       Date:  2008-12-13       Impact factor: 15.470

Review 3.  Mathematical modeling of molecular diffusion through mucus.

Authors:  Yen Cu; W Mark Saltzman
Journal:  Adv Drug Deliv Rev       Date:  2008-12-16       Impact factor: 15.470

4.  Role of measurement of nasal mucociliary clearance by saccharine test as a yard stick of success of functional endoscopic sinus surgery.

Authors:  Mangal Singh; Manish Chandra; S C Gupta; Devashish Sharma
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2010-10-12

5.  Optimization of an Intranasal Route for the Delivery of Human Neural Stem Cells to Treat a Neonatal Hypoxic-Ischemic Brain Injury Rat Model.

Authors:  Siliang Lu; Ke Li; Yinxiang Yang; Qian Wang; Yu Yu; Zhaoyan Wang; Zuo Luan
Journal:  Neuropsychiatr Dis Treat       Date:  2022-02-23       Impact factor: 2.989

Review 6.  Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa.

Authors:  Stella Gänger; Katharina Schindowski
Journal:  Pharmaceutics       Date:  2018-08-03       Impact factor: 6.321

Review 7.  Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System.

Authors:  Tyler P Crowe; Walter H Hsu
Journal:  Pharmaceutics       Date:  2022-03-12       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.